Personalized medicine: Genomics helps BC pharmacists target the right drugs for the right patient

October 28, 2014

October 28, 2014 – Genome British Columbia **Note to Editors** Both b-roll video and still photos are available. Vancouver, BC – An exciting new research project that aims to make personalized medicine a reality for patients is launching in a number of community pharmacies across British Columbia. The “Genomics for Precision Drug Therapy in the … Continue reading Personalized medicine: Genomics helps BC pharmacists target the right drugs for the right patient

Alectos Announces Preclinical Results in TAPP Mouse Model of Alzheimer’s Disease

October 26, 2014

October 26, 2014 – Alectos Oct. 26, 2014 – Alectos today announced publication of preclinical studies showing that pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in the TAPP mouse model of Alzheimer’s disease. For details, see: Yuzwa, S.A. et al. Mol Neurodegener 9:42 (2014).

Lilly, Zymeworks Announce Expansion of Strategic Licensing and Collaboration Agreement

October 22, 2014

October 22, 2014 – Zymeworks Inc. Indianapolis, IN and Vancouver, BC, Canada (October 22, 2014) – Zymeworks Inc. and Eli Lilly and Company (NYSE: LLY) today announced the expansion of their existing licensing and collaboration agreement. Originally announced in January 2014, the global strategic collaboration is focused on the development of an undisclosed number of … Continue reading Lilly, Zymeworks Announce Expansion of Strategic Licensing and Collaboration Agreement

Zymeworks Inc. Announces Over-Subscription of Previously Announced Private Placement in Conjunction with the Expansion of a Strategic Collaboration

October 22, 2014 – Zymeworks Inc. Vancouver, Canada (October 22, 2014) – Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class antibody and next generation protein-based therapeutics, today announced the close and over-subscription of a previously announced private placement. The financing included investments from new and existing shareholders, and extended the … Continue reading Zymeworks Inc. Announces Over-Subscription of Previously Announced Private Placement in Conjunction with the Expansion of a Strategic Collaboration

Sirona Biochem Announces Research Collaboration with Aegilops Applications

October 20, 2014

October 20, 2014 – Sirona Biochem Corp. Vancouver, British Columbia – October 20, 2014 – Sirona Biochem Corp. (TSX-V: SBM FSE: ZSB) today announced a collaboration with innovative French Company, Aegilops Applications. Aegilops specializes in the protection of plant seeds. The objective of the research collaboration is to develop a novel compound to improve germination … Continue reading Sirona Biochem Announces Research Collaboration with Aegilops Applications

Protecting Canada’s Forests using Next Generation Biosurveillance

October 15, 2014

October 15, 2014 – Genome British Columbia Vancouver, BC – A new $2.43 million research project, funded in part by Genome BC, has been approved to develop state of the art DNA biosurveillance detection tools for operational deployment. Preventing the introduction and establishment of Invasive Alien Species (IAS) such as the Asian gypsy moth and … Continue reading Protecting Canada’s Forests using Next Generation Biosurveillance

Milking It: Genomics is taking the guesswork out of dairy production

October 9, 2014

October 09, 2014 – Genome British Columbia Vancouver, BC – A new research program, funded in part by Genome British Columbia, aims to help BC’s dairy farmers by taking the guesswork out of determining which young heifers will develop to be the best milk producers. Through a simple hair sample, a genomic-based test will demonstrate … Continue reading Milking It: Genomics is taking the guesswork out of dairy production

Alectos Supports NSERC Funding for Prof. M.J. Boulanger at UVic

October 6, 2014

October 06, 2014 – Alectos October 6, 2014 – Alectos today announced its support for NSERC funding for the group of Prof. M.J. Boulanger at the University of Victoria, Department of Biochemistry & Microbiology, in a project titled “Cloning and expression of human glucocerebrosidase”. Parkinson’s disease (PD) is a worldwide health problem that is characterized … Continue reading Alectos Supports NSERC Funding for Prof. M.J. Boulanger at UVic

New Pulse Oximeter App-Device for iOS 8

September 25, 2014

September 25, 2014 – LionsGate Technologies Inc. (LGTmedical) Low-cost app-device that connects pulse oximeter sensors to mobile phones and tablets now available on iOS 8. VANCOUVER, BC, Canada – September 25, 2014 – LionsGate Technologies, Inc. (LGTmedical) has launched an iOS 8 pulse oximeter app-device called Kenek Edge™. “Apple says that iOS 8 just might … Continue reading New Pulse Oximeter App-Device for iOS 8

Sirona Biochem Launches Anti-aging Preclinical Studies

September 22, 2014

September 22, 2014 – Sirona Biochem Corp. Vancouver, British Columbia – September 22, 2014 –Sirona Biochem Corp. (TSX-V: SBM, FSE: ZSB) launches the next stage of development for its anti-aging compound library. With recent funding from Bpifrance (the French Public Investment Bank) and the district of Haute Normandie, Sirona Biochem’s subsidiary TFChem (France) moves into … Continue reading Sirona Biochem Launches Anti-aging Preclinical Studies